Table 1.
Characteristics of the study population
| Total | |
|---|---|
| Age (years) (mean ± SD) | 67 ± 7 |
| Race | |
| White (N, %) | 21, 91% |
| Black/African American (N, %) | 1, 4.5% |
| Asian | 1, 4.5% |
| Ethnicity | |
| Hispanic (N, %) | 3, 13% |
| Non-Hispanic (N, %) | 20, 87% |
| BMI (kg/m2) (mean ± SD) | 28 ± 8 |
| Underweight (BMI < 18.5) | 0, 0% |
| Normal (18.5 ≤ BMI < 25) | 11, 48% |
| Overweight (25 ≤ BMI < 30) | 4, 17% |
| Obese (BMI ≥ 30) | 8, 35% |
| Revision | 8, 35% |
| Smoking history | |
| Current (N, %) | 4, 17% |
| Former (N, %) | 8, 35% |
| Never (N, %) | 11, 48% |
| Supplement history | |
| Vitamin D (N, %) | 17, 74% |
| Calcium (N, %) | 12, 52% |
| Current use of medication for Osteoporosis | |
| Bisphosphonate (N, %) | 3, 13% |
| Teriparatide (N, %) | 1, 4.5% |
| Serum biochemistries (mean ± SD) | |
| 25 OH vitamin D (20-50 ng/mL) | 42 ± 16 |
| C-telopeptide (postmenopausal ref: 104-1008 pg/mL) | 544 ± 238 |
| Bone-specific alkaline phosphatase (postmenopausal ref: 7-22.4 ug/L) | 12 ± 6 |